Compound details
Heliocide B2
| Compound ID | CDAMM02667 |
|---|---|
| Common name | Heliocide B2 | IUPAC name | 2-hydroxy-3-methoxy-10a-methyl-7-(4-methylpent-3-enyl)-9,10-dioxo-4-propan-2-yl-8,8a-dihydro-5H-anthracene-1-carbaldehyde |
| Molecular formula | C26H32O5 |
| Retention time | 6.47 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 425.236 | Theoretical mz | 425.232 |
| Error | 9.7 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.4774 |
| Inchi key | FGQZFAWOAMMXKN-UHFFFAOYNA-N |
|---|---|
| Smiles | O=CC1=C(O)C(OC)=C(C=2C(=O)C3(C)CC=C(CCC=C(C)C)CC3C(=O)C12)C(C)C |
| Superclass | Benzenoids |
| Class | Anthracenes |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| Q96KS0 | EIT6 | HIF-prolyl hydroxylase 1 | T53904 | SwissTargetPrediction |
| P35462 | DRD3 | Dopamine D3 receptor | T02551 | SwissTargetPrediction |
| O14757 | CHEK1 | Serine/threonine-protein kinase Chk1 | T62449 | SwissTargetPrediction |
| P14061 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | T44011 | SwissTargetPrediction |
| P30291 | WEE1 | Serine/threonine-protein kinase WEE1 | T69991 | SwissTargetPrediction |
| P49810 | PSEN2 | Gamma-secretase | T99204 | SwissTargetPrediction |
| P25024 | CXCR1 | Interleukin-8 receptor A | T00884 | SwissTargetPrediction |
| Q14680 | MELK | Maternal embryonic leucine zipper kinase | T96892 | SwissTargetPrediction |
| Q13451 | FKBP5 | Peptidyl-prolyl cis-trans isomerase FKBP5 | T98337 | SwissTargetPrediction |
| P06881 | CALCA | Calcitonin gene-related peptide 1 | T93509 | SwissTargetPrediction |
| P21757 | MSR1 | Macrophage scavenger receptor types I and II | T50007 | SEA |
| Q9GZT9 | EGLN1 | Egl nine homolog 1 | T32880 | SwissTargetPrediction |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T53904 | DI0010 | Acute disease anaemia | [ICD-11: 3A90] | Q96KS0 | EIT6 |
| T02551 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P35462 | DRD3 |
| T02551 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P35462 | DRD3 |
| T62449 | DI0027 | Anal cancer | [ICD-11: 2C00] | O14757 | CHEK1 |
| T62449 | DI0172 | Head and neck cancer | [ICD-11: 2D42] | O14757 | CHEK1 |
| T62449 | DI0183 | Hodgkin lymphoma | [ICD-11: 2B30] | O14757 | CHEK1 |
| T62449 | DI0238 | Lung cancer | [ICD-11: 2C25] | O14757 | CHEK1 |
| T62449 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O14757 | CHEK1 |
| T62449 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | O14757 | CHEK1 |
| T62449 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14757 | CHEK1 |
| T62449 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14757 | CHEK1 |
| T69991 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P30291 | WEE1 |
| T69991 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P30291 | WEE1 |
| T69991 | DI0429 | Uterine ligament/parametrium/uterine adnexa neoplasm | [ICD-11: 2C72] | P30291 | WEE1 |
| T99204 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P49810 | PSEN2 |
| T99204 | DI0380 | Shoulder lesion | [ICD-11: FB53] | P49810 | PSEN2 |
| T99204 | DI0390 | Soft tissue disorder | [ICD-11: FB56] | P49810 | PSEN2 |
| T00884 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P25024 | CXCR1 |
| T96892 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q14680 | MELK |
| T96892 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q14680 | MELK |
| T96892 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | Q14680 | MELK |
| T96892 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | Q14680 | MELK |
| T96892 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | Q14680 | MELK |
| T96892 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | Q14680 | MELK |
| T93509 | DI0163 | General pain disorder | [ICD-11: 8E43] | P06881 | CALCA |